COVID-19 Global Report and Health

Global Distribution of Confirmed Novel Coronavirus (SARS-CoV-2) Cases - Analytical Report

COVID-19 tested samples (India) upto 15 Jan '21: 186 million

The number of tested samples has increased significantly from a daily average of 230k during the first week of July '20 to over a million daily samples tested by Q4/20. The COVID-19 vaccination programme in India commenced on Jan 16th '21 with over 191 000 innoculations administered. Two vaccines have been approved, ie Covashield (developed by Oxford-AstraZeneca) manufactured by Serum Institure of India and Covaxin (developed by Bharat Biotech in collaboration with ICMR) manufactured by Bharat Biotech.

Public Healthcare - Union Budget Allocation in 2020-21: ₹ 675 billion

Health and Environment Related Links